Literature DB >> 6180306

Adaptation of a retrovirus as a eucaryotic vector transmitting the herpes simplex virus thymidine kinase gene.

C J Tabin, J W Hoffmann, S P Goff, R A Weinberg.   

Abstract

We investigated the feasibility of using retroviruses as vectors for transferring DNA sequences into animal cells. The thymidine kinase (tk) gene of herpes simplex virus was chosen as a convenient model. The internal BamHI fragments of a DNA clone of Moloney leukemia virus (MLV) were replaced with a purified BamHI DNA segment containing the tk gene. Chimeric genomes were created carrying the tk insert in both orientations relative to the MLV sequence. Each was transfected into TK- cells along with MLV helper virus, and TK+ colonies were obtained by selection in the presence of hypoxanthine, aminopterin, and thymidine (HAT). Virus collected from TK+-transformed, MLV producer cells passed the TK+ phenotype to TK- cells. Nonproducer cells were isolated, and TK+ transducing virus was subsequently rescued from them. The chimeric virus showed single-hit kinetics in infections. Virion and cellular RNA and cellular DNA from infected cells were all shown to contain sequences which hybridized to both MLV- and tk-specific probes. The sizes of these sequences were consistent with those predicted for the chimeric virus. In all respects studied, the chimeric MLV-tk virus behaved like known replication-defective retroviruses. These experiments suggest great general applicability of retroviruses as eucaryotic vectors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6180306      PMCID: PMC369806          DOI: 10.1128/mcb.2.4.426-436.1982

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  33 in total

1.  Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene.

Authors:  M Grunstein; D S Hogness
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Construction of hybrid viruses containing SV40 and lambda phage DNA segments and their propagation in cultured monkey cells.

Authors:  S P Goff; P Berg
Journal:  Cell       Date:  1976-12       Impact factor: 41.582

4.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

5.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

6.  Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange.

Authors:  G K McMaster; G G Carmichael
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

7.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

8.  Translation of Drosophila melanogaster sequences in Escherichia coli.

Authors:  A Rambach; D S Hogness
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

9.  Propagation of a segment of bacteriophage lamda-DNA in monkey cells after covalent linkage to a defective simian virus 40 genome.

Authors:  D Ganem; A L Nussbaum; D Davoli; G C Fareed
Journal:  Cell       Date:  1976-03       Impact factor: 41.582

10.  Measurement of the sequence complexity of cloned Moloney murine leukemia virus 60 to 70S RNA: evidence for a haploid genome.

Authors:  H Fan; M Paskind
Journal:  J Virol       Date:  1974-09       Impact factor: 5.103

View more
  49 in total

Review 1.  Destiny of unspliced retroviral RNA: ribosome and/or virion?

Authors:  Melinda Butsch; Kathleen Boris-Lawrie
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 2.  Gene therapy in clinical medicine.

Authors:  S M Selkirk
Journal:  Postgrad Med J       Date:  2004-10       Impact factor: 2.401

3.  The avian retrovirus env gene family: molecular analysis of host range and antigenic variants.

Authors:  C A Bova; J C Olsen; R Swanstrom
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

Review 4.  Viral vectors: from virology to transgene expression.

Authors:  D Bouard; D Alazard-Dany; F-L Cosset
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

5.  Analysis of viral and somatic activations of the cHa-ras gene.

Authors:  C J Tabin; R A Weinberg
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

6.  Characterization of a retrovirus shuttle vector capable of either proviral integration or extrachromosomal replication in mouse cells.

Authors:  S A Berger; A Bernstein
Journal:  Mol Cell Biol       Date:  1985-02       Impact factor: 4.272

7.  Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene.

Authors:  A D Miller; M F Law; I M Verma
Journal:  Mol Cell Biol       Date:  1985-03       Impact factor: 4.272

8.  Regulated expression of a complete human beta-globin gene encoded by a transmissible retrovirus vector.

Authors:  R D Cone; A Weber-Benarous; D Baorto; R C Mulligan
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

Review 9.  Human Cardiac Gene Therapy.

Authors:  Kiyotake Ishikawa; Thomas Weber; Roger J Hajjar
Journal:  Circ Res       Date:  2018-08-17       Impact factor: 17.367

10.  Treatment of glioblastoma multiforme cells with temozolomide-BioShuttle ligated by the inverse Diels-Alder ligation chemistry.

Authors:  Klaus Braun; Manfred Wiessler; Volker Ehemann; Ruediger Pipkorn; Herbert Spring; Juergen Debus; Bernd Didinger; Mario Koch; Gabriele Muller; Waldemar Waldeck
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.